Musculoskeletal pain and co-morbid insomnia in adults; a population study of the prevalence and impact on restricted social participation. by Baker, S et al.
RESEARCH ARTICLE Open Access
Musculoskeletal pain and co-morbid
insomnia in adults; a population study of
the prevalence and impact on restricted
social participation
Shula Baker1* , John McBeth1,2, Carolyn A. Chew-Graham1,3 and Ross Wilkie1
Abstract
Background: Comorbidity is common in patients consulting in primary care. Musculoskeletal pain and insomnia
each increase the risk of the other. Co-occurrence may pose an increased burden on well-being. However, the
prevalence and impact of co-existing pain and insomnia in adults living in the community who may present to
primary care is unclear. The aim of this study was to report the prevalence of pain and insomnia in adults
registered with primary care, and to examine the impact of co-occurrence on social activities.
Methods: This population-based prospective cohort study of adults aged ≥18 years (n = 1181) used health survey
data collected via baseline and 12 month follow-up questionnaires. Baseline data on pain, insomnia (4 symptoms:
delayed sleep onset, difficulty maintaining sleep, early waking and non-restorative sleep) and putative confounders
and social activity restriction at follow up was collected. Associations between baseline pain, insomnia and
restricted social activities (RSA) at 12 months were examined using logistic regression, with adjustment for
confounders. Interaction terms between pain and each insomnia symptom were examined in final models.
Results: Mean respondent age was 49.6 (SD ± 15.2) years, 55.7% were female. At baseline, 880 (74.5%) reported
pain, 122 (10.3%) delayed sleep onset, 298 (25.2%) difficulty maintaining sleep, 188 (15.9%) early wakening, and 215
(18.2%) reported non-restorative sleep. At follow-up 200 (16.9%) reported RSA. Pain and each insomnia symptom
were associated with RSA at 12 month follow-up; pain [unadjusted odds ratio (OR:2.3;95%CI:1.5,3.5), delayed sleep
onset (OR:6.1;95%CI:4.0,9.1), difficulty maintaining sleep (OR:3.2;95%CI:2.3,4.4), early wakening (OR:4.1;95%CI:2.9,5.9),
and non-restorative sleep (OR:4.0; 95%CI:2.8,5.8). Only delayed sleep onset (OR:2.6;95%C:1.5,4.5) remained
significantly associated with restricted social activities in the fully adjusted model. There was a significant interaction
between pain and delayed sleep onset (OR:0.3;95%CI:0.1,0.99; p = .049) and restricted social activity at 12 months in
the final multivariable model.
Conclusions: Pain and insomnia commonly co-occur, resulting in greater impact upon subsequent functional
ability. Delayed sleep onset is the insomnia symptom most strongly associated with reduced functional ability.
Clinicians should be aware of the common co-occurrence of insomnia symptoms, inquire about sleep in patients
consulting with pain, and offer interventions that target both sleep and pain.
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Background
Musculoskeletal pain is common in adults and is a fre-
quent reason for consultation to primary health care [1].
One quarter to one third of the general population re-
port low back, hip or shoulder pain and one in five ex-
perience chronic pain (i.e. pain that lasts for three
months or more) [2, 3]. Musculoskeletal pain impacts
on physical and mental health, and mortality risk [4, 5].
Thirty percent of adults in the general population report
significant sleep disturbance and 6% to 10% meet diag-
nostic criteria for insomnia [6], defined as difficulty initi-
ating or maintaining sleep, or nonrestorative sleep, for at
least 1 month [7]. Left untreated, insomnia is associated
with an increased incidence of depression, anxiety [8]
and worse physical health [9]. Insomnia frequently oc-
curs in patients with chronic pain with the prevalence of
co-occurrence ranges between 50% and 88% [10, 11].
However, the prevalence and impact of co-existing mus-
culoskeletal pain and insomnia in adults living in the
community who may present to primary care is unclear.
Musculoskeletal pain and insomnia have a reciprocal
relationship, with each condition increasing the risk of
the other which may augment the burden on health and
well-being [12]. The mechanisms underlying the associ-
ation appear to be complex and multi-factoral. Sleep dis-
ruption may be attributed to musculoskeletal pain
arising from painful stimuli during sleep, which can in-
duce microarousal and increase wakefulness [11]. There
is also evidence to suggest that recurrent sleep
deprivation and disruption (especially disruption of slow
wave sleep) for three consecutive nights or more can de-
crease an individual’s pain threshold, amplify negative
mood and produce somatic symptoms [10, 11].
Social participation involves taking part in social activ-
ities and hobbies as well as fulfilling social roles such as
being a worker, carer or community member [13]. Main-
taining social participation is a clinically important out-
come, potentially modifiable by intervention, and a
target for intervention in primary care [14]. Restricted
social activity is associated with higher rates of morbidity
and mortality and lower life satisfaction and health-related
quality of life [15, 16]. The aim of this prospective cohort
study was to report the prevalence of co-morbid pain and
insomnia in community-dwelling adults registered with
primary care and its association with restricted social
activities.
Methods
Study design and procedure
The study was a population-based prospective cohort
study exploring headache prevalence in the general adult
population. Five general practices were selected from 15
practices constituting the North Staffordshire GP Re-
search Network, to contain a mix of urban and rural
settings, and a spread of social class. The practice age/
sex registers were downloaded with unique identifiers
and sampling was conducted by obtaining randomly
generated samples of 1000 persons, aged 18 and over,
from each of 5 general practices in North Staffordshire
(total sample of 5000). The sample size was determined
based upon expected headache prevalence. As this study
was concerned with pain in any body part, so included
many additional pain sites, the sample size was also suf-
ficient for the purpose of this research question. After
excluding those individuals who had recently moved,
died or were unable to participate due to ill health (N =
243,4.9%) a total of 4757 persons were invited to take
part in the study. In the UK over 95% of the population
are registered with a general practice and provide repre-
sentative samples of the general population [17]. Ethical
approval was obtained from the North Staffordshire
Local Research Ethics Committee. All participants pro-
vided informed consent to participate in the study.
Baseline survey
Potential participants were mailed a baseline question-
naire that collected data on pain, insomnia and putative
confounders.
Assessment of musculoskeletal pain
To assess musculoskeletal pain participants were asked
to indicate the site of any pain lasting one day or longer
that they had experienced during the last month on a
blank body manikin (front and back views). Pain mani-
kins are valid and reliable tools for recording pain preva-
lence in self-administered questionnaires [18, 19]. Using
their reports of pain, participants were classified into
‘any pain’ (any shading of pain on the manikin) or ‘no
pain’ (no shading) groups.
Identification of insomnia
The four-item Estimation of Sleep Problems Scale [20]
was used to examine sleep quality and identify insomnia.
The scale asks about recent problems with sleep and
contains items on the most commonly occurring symp-
toms of poor sleep quality: delayed sleep onset (‘During
the past four weeks did you have trouble falling asleep?’);
sleep maintenance (‘During the past four weeks did you
wake up several times per night?’); early wakening (‘Dur-
ing the past four weeks did you have trouble staying
asleep, including waking up far too early?’); and non-
restorative sleep (‘During the past four weeks did you
wake up after your usual amount of sleep feeling tired
and worn out?’). Participants indicate the frequency in
the past month that they have experienced difficulties in
each of the four sleep components on a 3-point scale
ranging from 0 to 2 (0 = not at all; 1 = on some nights; 2
= on most nights). For this analysis “on most nights” was
Baker et al. BMC Family Practice  (2017) 18:17 Page 2 of 9
used to define the presence of each respective sleep
problem. This method of determining those with insom-
nia has been validated for use both in individuals with
pain [21] and the general population [22].
Putative confounders
Putative confounders were demographics (age, gender),
and socio-economic status (occupational class: manual
(skilled manual, partly-skilled or unskilled roles profes-
sional/managerial, semi-routine, routine) / non-manual
(professional, managerial or skilled non-manual roles)),
anxiety, depression and physical health related quality of
life. Levels of anxiety and depression were measured
using the Hospital Anxiety and Depression Scale
(HADS) [23]. The HADS performs well in assessing se-
verity and identifies cases of anxiety and depression in
hospital practice, for which it was first designed, primary
care and in the general population [24]. The sensitivity
and specificity of each scale to detect cases when clinical
diagnosis is considered as the gold standard ranges be-
tween 70 and 80% [24, 25]. The HADS, along with the
Geriatric Depression Scale, have been identified as the
best instruments to measure mood and behaviour in
older adults in observational studies and trials, scoring
highly for practicality, feasibility, psychometric proper-
ties and relevant content [26]. The HADS scale consists
of 14 items scored on a Likert scale of 0–3: 7 items ask
about symptoms of anxiety and give a total score of 0–21,
and 7 items ask about symptoms of depression, giving a
total score of 0–21. Higher scores represent more frequent
symptoms of depression/anxiety. For both scales scores of
0–7 were classified as a non-case, 8–21 a probable case
using guidelines by the original authors [23]. Scores of ≤7
are considered ‘normal’ in the general adult population,
while those of 8 or more are suggestive of a disorder [24].
HADS has been shown to have good sensitivity and speci-
ficity when a cut-off of ≤7 is used to identify probably
cases of depression and anxiety in samples of primary care
patients [24].
Physical health related quality of life was measured
using the Medical Outcomes Short-Form 12 (SF-12)
physical component summary score [27]. Computation
of the PCS component was achieved by multiplying each
indicator variable by a respective physical regression
weights provided as part of the SF-12 scoring algorithm
[27]. As in other studies [28], PCS score tertiles were
then used in the analyses for the ease of interpretation,
with the highest third used as the referent group.
Identifying restricted social activity at follow-up
Participants who returned a baseline questionnaire, and
who agreed to further contact, were mailed a follow-up
questionnaire 12 months later. A single item from the
SF-12 was used to measure RSA at 12 month review;
‘Has your health limited your social activities (like visit-
ing friends or close relatives)?’ RSA was defined as re-
sponses of ‘All’/’Most’/’A good bit’/’Some of the time’,
and those responding ‘A little bit of the time’ or ‘None
of the time’ were defined as not having RSA. This point
was chosen based upon the extent of restriction reported
being judged as likely to reduce functional ability, and
the total number reporting RSA exceeding 10% of the
overall sample. Baseline RSA was included as a putative
confounder, and was measured and categorised using
the same method.
Statistical analysis
A complete-case analysis was conducted that included
only those participants with complete data at baseline
and follow-up. First, the distribution of baseline vari-
ables were examined by pain and insomnia status
with differences tested for significance using Chi-
square or Kruskal Wallis tests where appropriate.
Bootstrapped (n = 1000) 95% confidence intervals were
calculated for the prevalence of pain and each insom-
nia symptom to provide an estimation for the study
population. Univariate logistic regression models ex-
amined the relationship between pain and insomnia,
and RSA at 12 month follow-up, adjusting for age,
gender, and occupational class. Pain and insomnia
were then included in the same multivariate model
which was cumulatively adjusted for: i) putative con-
founders age, gender and occupational class (model
1), ii) anxiety, depression and physical health related
quality of life (model 2), iii) baseline social participa-
tion (model 3). Finally, to determine whether the
association between pain and RSA at 12 month
follow-up was moderated by insomnia, an interaction
term between pain and each insomnia symptom was
included separately adjusting for all confounders
(model 4), and then all interaction terms were in-
cluded in the same model. Outliers were tested for by
looking at for studentized residuals larger than 3 for
all variables in the model. None were found.
Continuous covariates were standardised prior to entry
into the regression analysis. Results are reported as odds
ratios (OR) with 95% confidence intervals (95%CI).
Model goodness of fit was examined for each model
using the area under the Receiver Operating Character-
istic curve (AUROC) to examine predictive power, and
the Hosmer-Lemeshow test to highlight the goodness-
of-fit to the data. AUROC values are measures of a
model’s ability to discriminate between those with RSA
at 12 months and those without. Traditionally values of
0.7 or more represent moderate accuracy/discrimination
[29]. Analysis was performed using SPSS 19.0 and Stata
13.0 for Windows
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Results
Of 4757 participants who were eligible to take part, 2662
(56.0%) returned a completed questionnaire at baseline.
Compared to participants, non-participants were youn-
ger (mean age: 47 years cf. 51 years; p < 0.001) and more
likely to be male (52 cf. 42%; p < 0.001). After excluding
those who refused further contact (n = 247), decedents
(n = 84), those who did not respond at follow-up (n =
340), or had incomplete data (n = 810), 1181 persons
were available for analysis at follow up (Fig. 1). Compari-
son to UK Census data [30] showed the analytical sam-
ple to be similar in terms of gender (55.7 female cf.
51.9%) with fewer young adults (19.1% aged 18–34 cf.
29.4%) and more middle aged adults (61.4% aged 35–64
cf. 50.0%).
Participant characteristics
Participant mean age was 49.6 (Standard Deviation (SD)
±15.2) years and 658 (55.7%) were female (Table 1). At
baseline, 880 (74.5%) reported pain and 411 (34.8%) re-
ported one or more insomnia symptoms; 122 (10.3%) re-
ported delayed sleep onset, 298 (25.2%) difficulty
maintaining sleep, 188 (15.9%) early wakening, and 215
(18.2%) non-restorative sleep. The proportion of individ-
uals with each respective sleep problem who reported
additional sleep problems is shown in Table 2. 349
(29.6%) responders reported both pain and insomnia.
This was 39.7% of those who reported pain, and 84.9%
of those who reported insomnia. At 12 month follow-up,
200 (16.9%) reported RSA. Of this group, 109 (54.5%) re-
ported pain and insomnia at baseline, 62 (31.0%) re-
ported pain only, 17 (8.5%) reported one or more
insomnia symptoms and 12 (6.0%) reported neither pain
nor insomnia.
The association between baseline pain, insomnia
symptoms and restricted social activity
Pain and all four insomnia symptoms were associ-
ated with RSA at 12 month follow-up; baseline pain
[unadjusted odds ratio (OR:2.3;95%CI:1.5,3.5), de-
layed sleep onset (OR:6.1;95%CI:4.0,9.1), difficulty
maintaining sleep (OR:3.2;95%CI:2.3,4.4), early wak-
ening (OR:4.1;95%CI:2.9,5.9), and non-restorative
sleep (OR:4.0;95%CI:2.8,5.8). All symptoms were sta-
tistically significant (p < .001).
When pain and insomnia symptoms were included
in the multivariable model with adjustment for age,
gender and occupational class (model 1), the associa-
tions attenuated; difficulty maintaining sleep
(OR:1.3;95%CI:0.8,2.1;p = .173) and early wakening
(OR:1.5;95%CI:0.8,2.6;p = .265) were not significantly
associated with RSA at 12 month follow-up. When
adjusted for comorbidity (model 2), the associations
between RSA at 12 month follow-up and pain and non-
restorative sleep attenuated to non-significance (p = .918).
Delayed sleep onset (OR:2.6;95%CI:1.5,4.5;p = .001)
remained significantly associated with RSA in the fully ad-
justed model (model 3). Results for multivariable analyses
are given in Table 3.
Interactions between pain and difficulty maintaining
sleep, early wakening and non-restorative sleep were
none significant predictors of RSA at 12 month
follow-up (p > 0.05). Although significant, the coeffi-
cient for the interaction term between pain and de-
layed sleep onset in the final multivariable model was
less than 1 (OR:0.3;95%CI:0.1,0.99;p = .049), indicating
the combined effect to be less than that expected
were the effect of the two factors to be totally inde-
pendent of each other. When all interaction terms were
included in the same model, the odds ratio for pain be-
came insignificant (OR:1.6;95%CI:0.8,3.0;p = .180), and
only delayed sleep onset remained significant of the in-
somnia symptoms (OR:2.6;95%CI:1.5,4.5;p = .001). In
addition to delayed sleep onset, baseline depression
(OR:1.5;95%CI:1.3,1.8;p < .001), low physical health related
quality of life (OR:1.9;95%CI:1.2,3.2;p = 0.01), and baseline
RSA (OR:4.6;95%CI:3.0,7.1;p < .001) were independently
associated with RSA at follow-up in the final multivariable
model.
Questionnaires mailed
(n=4885)
Responded at baseline 
(n=2698)
Adjusted response 
(n=2662)
Responded to pain and 
disrupted sleep questions 
at baseline 
(n =2363)
Consent to further 
participation    
(n=2116)
Deaths/ left practice (n=57)
Returned address unknown 
(n=71)                               
No response (n=2059)
Not completed by intended 
recipient (n=36)
Did not complete baseline 
disrupted sleep questions 
(n=299)
Reported social activity 
status at follow-up             
(n=1181)
Did not consent to further 
participation (n=247)
Died/ Left practice (n=84) 
No response at follow-up 
(n=340)                     
Responded with incomplete 
outcome data (n=511)
Fig. 1 Flow diagram of participants
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Table 1 Participant characteristics by baseline pain and insomnia status
Overall No pain or insomnia Pain only Insomnia only Pain and insomnia p-value
Group size p < 0.001
(%) 1181 (100%) 239 (20.2%) 531 (45.0%) 62 (5.2%) 349 (30.0%)
AgeK p = 0.015
Median (IQR) 49.6 (± 15.2) 49.4 (±15.3) 48.3 (±14.8) 52. 1 (±15.0) 51.4 (±15.8)
GenderC p = 0.003
Female No. (%) 658 (55.7%) 122 (51.0%) 277 (52.2%) 41 (66.1%) 218 (62.5%)
OccupationC
Manual (%)
p = 0.903
Delayed sleep onsetC
Restricted No. (%)
122
(10.3%)
- - 18
(29.0%)
104
(29.8%)
Difficulty maintaining sleepC
Restricted No. (%)
298
(25.2%)
- - 48
(77.4)
250
(71.6%)
p = 0.347
Early wakingC
Restricted No. (%)
188
(15.9%)
- - 33
(53.2%)
155
(44.4%)
p = 0.199
Non-restorative sleepC
Restricted No. (%)
215
(18.2%)
- - 26
(41.9%)
189
(54.2%)
p = 0.076
Baseline RSAC
Restricted No. (%)
203
(17.2%)
11
(4.6%)
53
(10.0%)
10
(16.1%)
129 (37.0%) p < 0.001
Baseline SF-12 physical functionA
Median PCS score. (IQR)
48.5
(± 10.5)
54.3
(±4.7)
49.4
(±8.9)
51.2
(±10.0)
42.5
(±12.6)
p < 0.001
Baseline AnxietyC
Possible/probable No. (%)
460
(39.0%)
38
(15.9%)
159
(29.9%)
27
(43.5%)
236
(67.6%)
p < 0.001
Baseline DepressionC
Possible/probable No. (%)
206
(17.4%)
38
(5.4%)
45
(8.5%)
15
(24.2%)
133
(38.1%)
p < 0.001
12 month review RSAC
Restricted No. (%)
200
(16.9%)
12
(5.0%)
62
(11.7%)
17
(27.4%)
109
(31.2%)
p < 0.001
RSA restricted social activity
A One-way ANOVA analysis, K- Kruskal Wallis analysis, C- Chi square analysis
Table 2 The number and proportion of individuals with each insomnia symptom and pain (by column) who reported each of the
other insomnia symptoms (by row)
Symptom,
number reporting
(%)
Pain
N = 880
74.5%
Delayed sleep onset
N = 122
10.3%
Poor sleep maintenance
N = 298
25.2%
Early wakening
N = 188
15.9%
Non-restorative sleep
N = 215
18.2%
95% CI for population prevalence 71.9-77.1% 8.4%-2.1% 22.7-28.1% 13.8-17.9% 15.9-20.5%
Pain - 104
(85.2%)
250
(83.9%)
155
(82.4%)
189
(87.9%)
Delayed sleep onset 104
(11.8%)
- 94
(31.5%)
89
(47.3%)
74
(34.4%)
Poor sleep maintenance 250
(28.4%)
94
(77.0%)
- 175
(93.1%)
127
(59.1%)
Early wakening 155
(17.6%)
89
(73.0%)
175
(58.7%)
- 102
(47.4%)
Non-restorative sleep 189
(21.5%)
74
(60.7%)
127
(42.6%)
102
(54.3%)
-
No other sleep problems 62
(31.0%)
15
(12.3%)
91
(30.5%)
7
(3.7%)
76
(35.3%)
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Discussion
The study reports the extent of co-occurrence of pain
and insomnia in a primary care population, and the ex-
tent of its association with problems getting out and
about, and engaging in social activities. The findings
highlight the common occurrence of musculoskeletal
pain and insomnia in adults in primary care patients; al-
most one third patients reported co-existing pain and in-
somnia. More than four in every five respondents with
insomnia reported pain. Baseline pain and each sleep
problem were associated with RSA at 12 month follow-
up. The association between RSA at follow-up and pain,
difficulty maintaining sleep, early wakening and non-
restorative sleep attenuated with adjustment for depres-
sion, anxiety, physical health related quality of life and
baseline RSA. However, delayed sleep onset was
significantly associated with RSA at 12 month follow-up
following adjustment for all confounders.
There was no multiplicative interaction between pain
and insomnia defined by difficulty maintaining sleep,
early wakening or non-restorative sleep. However there
was evidence that the relationship between baseline pain
and RSA at follow up was augmented by the presence of
an insomnia symptom. For example, having pain but not
insomnia was not significantly associated with RSA at
follow-up (p = .180), whereas this increased to a greater
than 7-fold increase in odds of RSA when delayed sleep
onset was present (OR:7.4;95%CI:4.2,13.0).
The prevalence of insomnia symptoms in this study is
comparable with the 10-40% reported in other popula-
tion surveys [31, 32]. The prevalence of pain (72%) was
high but is comparable to that reported in previous
Table 3 Association between baseline pain and insomnia symptoms and restricted social activity at follow-up
Model I Model II Model III Model IV
Baseline Pain 1.8*
(1.2,2.9)
1.1
(0.7,1.8)
1.1
(0.6,1.8)
1.3
(0.7,2.4)
Delayed sleep onset 2.9**
(1.8,4.8)
2.4**
(1.4,4.1)
2.6**
(1.5,4.5)
7.6**
(2.3,25.4)
Difficulty maintaining sleep 1.3
(0.8,2.1)
1.1
(0.7,1.8)
1.0
(0.6,1.6)
1.0
(0.6,1.6)
Early waking 1.5
(0.8,2.6)
1.4
(0.8,2.5)
1.4
(0.7,2.5)
1.3
(0.7,2.5)
Non-restorative sleep 2.0**
(1.3,3.1)
1.0
(0.6,1.6)
0.9
(0.6,1.5)
0.9
(0.6,1.5)
Age 1.5**
(1.2,1.8)
1.2
(0.98,1.5)
1.2
(0.9,1.5)
1.2
(0.9,1.5)
Gender 1.2
(0.97,1.4)
1.1
(0.9,1.4)
1.2
(0.97,1.4)
1.2
(0.96,1.4)
Manual occupation 1.2
(0.98,1.4)
1.1
(0.9,1.3)
1.0
(0.8,1.2)
1.0
(0.8,1.2)
Possible/probable Depression - 1.8**
(1.5,2.1)
1.5**
(1.3,1.8)
1.5**
(1.2,1.8)
Possible/probable Anxiety - 1.3*
(1.0,1.6)
1.2
(0.9,1.4)
1.2
(0.9,1.5)
Poor physical function (Lowest tertilea) - 2.7**
(1.7,4.4)
1.9*
(1.1,3.2)
2.0**
(1.2,3.3)
Moderate physical function (mid tertilea) - 1.3
(0.8,2.2)
1.2
(0.7,2.1)
1.2
(0.7,2.0)
Baseline RSA - - 4.6**
(3.0,7.1)
4.6**
(3.0,7.1)
Pain x delayed sleep onset interaction - - 0.3*
(0.1,0.99)
Model fit: AUROC 0.730 0.805 0.829 0.830
Hosmer-Lemeshow test p = .308 (83.2%) p = .435
(85.4%)
p = .394
(86.5%)
p = .414
(86.6%)
Multivariate model I: Pain, each insomnia symptom, and sociodemographic factors. Model II: Pain, each insomnia symptom, sociodemographic factors, anxiety,
depression and physical health related quality of life. Model III: Pain, each insomnia symptom, sociodemographic factors, anxiety, depression, physical health
related quality of life and baseline social participation. Model IV: Model 3 plus the inclusion of an interaction term between pain and delayed sleep onset. All
values are Exp (beta) with 95% confidence intervals. * p < 0.05, ** p < 0.01, − variable not included in the model
aReferent group was those participants in the tertile with the highest physical function scores
AUROC – Area Under the Receiver Operator Characteristic curve. Hosmer & Lemeshow test reported as p-value (insignificant p-value indicates good fit)
and proportion of cases correctly classified
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studies of community-dwelling adults [33–35]. The
levels of co-occurring insomnia and pain were compar-
able with other studies [36, 37]. The association between
musculoskeletal pain and RSA and insomnia and RSA
have been reported in older adults but not in the general
adult population. A systematic review of available litera-
ture (details available from the corresponding author)
found no comparable population studies that have re-
ported on the impact of estimates of co-occurring pain
and insomnia and their impact on restricted social
activity.
This study includes a number of strengths and limita-
tions. The 1181 participants were recruited from general
practice registers, which provide a sampling frame repre-
sentative of the general population [17]. Furthermore,
the response rates were comparable with other popula-
tion based prospective studies that have used postal
questionnaires. As in all longitudinal studies there was
some attrition and missing data. Responders to the base-
line survey were more likely to be younger and female.
Those included in the analysis, compared to those who
responded at baseline but not to the follow-up question-
naire, were less likely to have pain at baseline (p = 0.002)
and more likely to be younger (p < 0.001), but they were
no more likely to have insomnia at baseline (p = 0.67) or
be female (p = 0.89). Non-participation bias may occur
but it is unknown if the relationship between pain, in-
somnia and RSA in those who did not respond is differ-
ent to those included in the analysis. The generalizability
of the data may be limited by the characteristics of the
study sample; the area covered by the study is more de-
prived in terms of health, education, and employment,
but has fewer barriers to housing and services, than
England as a whole.
The available data covered potential confounders of
the relationship between pain and insomnia and RSA,
however other potential confounders of the relationship
have not been included (e.g. educational attainment).
The questionnaires used to measure insomnia, anxiety,
depression and RSA have been validated for use in gen-
eral population samples and in postal surveys. RSA was
operationalised as a binary measure, produced by dichot-
omising the six-level of responses to a single question. A
sensitivity analysis, performed to check whether the
choice of cut-off affected the relationship between sleep
and RSA, found the association was not dependent on
the cut-off used to define RSA. Pain was assessed using
blank body manikins, a standard data-capture method
used in postal surveys. This method has been shown to
be a valid and reliable assessment of pain in mid-life
adults, although the validity of manikin-derived pain in
older people is less clear. High levels of inter-rater reli-
ability for pain scoring (Kappa >0.60) has been demon-
strated using this data-capture method [20].
In the pilot work for this study, there were some re-
sponders who reported pain interfering with work and
but did not indicate pain on the manikin. This may have
occurred because pain that interferes with work may not
last for one day or longer and would not be reported on
the manikin. The high prevalence of pain suggests that
recall bias may be present, however the estimates are
comparable with other studies that have measured the
same phenotype (any pain that have lasted for a day or
longer in the last month). It is also possible that pain
captured includes that which is not musculoskeletal in
origin which would inflate the prevalence estimates,
however the majority of pain lasting one day or longer
that is reported by adults in primary care is likely to be
musculoskeletal in origin [35]. It is also possible that
pain intensity may influence the association of musculo-
skeletal pain upon subsequent social activity restriction,
as musculoskeletal pain intensity has been shown to pre-
dict greater negative health impact [38]. This study con-
siders pain arising in any part of the body, future
research could examine whether the specific location of
pain, or pain phenotype (e.g. widespread, regional or
none) influence the association with RSA. The co-
occurrence of sleep problems was high, with early
awakening and delayed sleep onset rarely occurring in
isolation (3.7% and 12.3% of individuals reported isolated
symptoms respectively). While early awakening was
most likely to co-occur with waking several times (93.1%
of those with early awakening), delayed sleep onset often
co-occurred with each of the other insomnia symptoms
(60.7%, 73.0% and 77.0% respectively) suggesting it may
be a marker of more severe symptoms. This may explain
why delayed sleep onset was found to be most strongly
associated with subsequent restricted participation.
This study has implications for primary care clinicians.
Firstly, results support the idea that all adults consulting
with musculoskeletal pain should be asked about con-
current insomnia, and patients who present with sleep
problems should be asked about pain. The study indi-
cates the importance of offering interventions to people
where pain or sleep problems are identified. Current
management options are limited and tend to target pain
and insomnia separately: General practitioners can pre-
scribe analgesics which target pain or, drugs which influ-
ence sleep (although these should not be prescribed
long-term, due to the risk of addiction) and there is evi-
dence to support such approaches [39]. However, there
are known adverse effects to some medications that may
limit their usefulness [39]. Psychological therapies and
exercise are also known to be beneficial but are not
commonly available [40]. A multidisciplinary holistic ap-
proach to management is likely to be the way forward
[41]; however access to pain clinics which offer such an
approach may be limited.
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Approaches that reduce pain and insomnia is neces-
sary to offer acceptable treatments for the large number
of adults in the general population who experience both
symptoms. Primary care clinicians provide support to
patients to manage their symptoms and act as gate-
keepers to onward referral. They should systematically
explore the range of symptoms when a patient presents
a single problem, such as pain or sleep disturbance, in-
cluding symptoms of anxiety and depression. In
addition, the clinician should explore social circum-
stances of the patient, including range of social contacts.
The clinician can then give specific advice about the
constellation of symptoms and problems that the patient
may have, and which are likely to be interacting with
each other. Such advice should include education about
the possible interaction between sleep disturbance and
pain and facilitation of increasing social activity, and en-
gagement with the third sector to promote patient and
self-management. Patients receiving interventions that
target mood and physical ability have potential to im-
prove social participation which acts as a buffer against
morbidities such as cardiovascular disease [42] and
maintains healthy ageing [16, 43].
Conclusions
This study highlights co-occurring pain and insomnia as
a prevalent problem in the general population, and sug-
gests that those reporting both conditions experience
greater impact upon social activity participation than
those with only one condition. The study findings sug-
gest co-occurring pain and insomnia may be an import-
ant target for clinical trials, rather than considering
treatments for isolated symptoms. RSA risk factors
which are potentially modifiable and treatable, such as
anxiety and depression, present important targets for in-
terventions and should be considered by those commis-
sioning services. Further studies are warranted to
determine how best to promote social activity participa-
tion in older people with comorbid pain and insomnia.
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